Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
暂无分享,去创建一个
D. Corcoran | R. Shenkar | I. Awad | D. Marchuk | Changbin Shi | C. Gallione | M. Berg | David A. McDonald | Amy L Akers | N. De Castro | Stephanie Li
[1] J. Mulliken,et al. Somatic uniparental isodisomy explains multifocality of glomuvenous malformations. , 2013, American journal of human genetics.
[2] R. Shenkar,et al. Fasudil Decreases Lesion Burden in a Murine Model of Cerebral Cavernous Malformation Disease , 2012, Stroke.
[3] K. Heesom,et al. Phasic contractions of isolated human myometrium are associated with Rho-kinase (ROCK)-dependent phosphorylation of myosin phosphatase-targeting subunit (MYPT1) , 2011, Molecular human reproduction.
[4] M. Walsh,et al. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ. , 2011, Archives of biochemistry and biophysics.
[5] R. Kucherlapati,et al. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. , 2011, Human molecular genetics.
[6] R. Shenkar,et al. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity , 2010, The Journal of experimental medicine.
[7] N. Sciaky,et al. Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype* , 2010, The Journal of Biological Chemistry.
[8] M. Aboian,et al. The putative role of the venous system in the genesis of vascular malformations. , 2009, Neurosurgical focus.
[9] J. Gault,et al. CEREBRAL CAVERNOUS MALFORMATIONS: SOMATIC MUTATIONS IN VASCULAR ENDOTHELIAL CELLS , 2009, Neurosurgery.
[10] N. Sciaky,et al. Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells , 2009, Journal of Biological Chemistry.
[11] G. Steinberg,et al. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. , 2009, Human molecular genetics.
[12] Christopher A. Jones,et al. The Cerebral Cavernous Malformation signaling pathway promotes vascular integrity via Rho GTPases , 2009, Nature Medicine.
[13] U. Felbor,et al. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells , 2008, Human molecular genetics.
[14] C. Nusbaum,et al. Quality scores and SNP detection in sequencing-by-synthesis systems. , 2008, Genome research.
[15] R. Allende,et al. EXTREME DE NOVO APPEARANCE OF CEREBRAL CAVERNOUS MALFORMATIONS: CASE REPORT , 2008, Neurosurgery.
[16] E. Vicaut,et al. Genotype–phenotype correlations in cerebral cavernous malformations patients , 2006, Annals of neurology.
[17] D. Marchuk,et al. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. , 2005, Human molecular genetics.
[18] J. Gault,et al. Biallelic Somatic and Germ Line CCM1 Truncating Mutations in a Cerebral Cavernous Malformation Lesion , 2005, Stroke.
[19] M. Clanet,et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. , 2005, American journal of human genetics.
[20] P. Frérebeau,et al. Mutations within the MGC4607 gene cause cerebral cavernous malformations. , 2004, American journal of human genetics.
[21] C. Liquori,et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. , 2003, American journal of human genetics.
[22] S. Shafikhani. Factors affecting PCR-mediated recombination. , 2002, Environmental microbiology.
[23] J. W. Thomas,et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). , 1999, Human molecular genetics.
[24] A. Joutel,et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas , 1999, Nature Genetics.
[25] F. Giangaspero,et al. Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. , 1996, Neurosurgery.
[26] John R. Robinson,et al. Natural history of the cavernous angioma. , 1991, Journal of neurosurgery.
[27] A. Elster,et al. An analysis of the natural history of cavernous angiomas. , 1991, Journal of neurosurgery.
[28] R. Spetzler,et al. Cerebral cavernous malformations. , 1989, Archives of neurology.
[29] B. Rilliet,et al. [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. , 1989, Neuro-Chirurgie.
[30] M. Hadley,et al. Cerebral cavernous malformations. Incidence and familial occurrence. , 1988, The New England journal of medicine.
[31] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.